Search Results - "Hauch, Richard"

Comprehensive characterization of central BCL-2 family members in aberrant eosinophils and their impact on therapeutic strategies by Odinius, Timo O., Buschhorn, Lars, Wagner, Celina, Hauch, Richard T., Dill, Veronika, Dechant, Marta, Buck, Michele C., Shoumariyeh, Khalid, Moog, Philipp, Schwaab, Juliana, Reiter, Andreas, Brockow, Knut, Götze, Katharina, Bassermann, Florian, Höckendorf, Ulrike, Branca, Caterina, Jost, Philipp J., Jilg, Stefanie

“…Purpose Hypereosinophilia represents a heterogenous group of severe medical conditions characterized by elevated numbers of eosinophil granulocytes in…”
Get full text

Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose by Jilg, Stefanie, Hauch, Richard T, Kauschinger, Johanna, Buschhorn, Lars, Odinius, Timo O, Dill, Veronika, Müller-Thomas, Catharina, Herold, Tobias, Prodinger, Peter M, Schmidt, Burkhard, Hempel, Dirk, Bassermann, Florian, Peschel, Christian, Götze, Katharina S, Höckendorf, Ulrike, Haferlach, Torsten, Jost, Philipp J

“…Patients with Myelodysplastic Syndromes (MDS) and secondary Acute Myeloid Leukemia (sAML) have a very poor prognosis after failure of hypomethylating agents…”
Get full text

Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profile by Reidel, Veronika, Kauschinger, Johanna, Hauch, Richard T, Müller-Thomas, Catharina, Nadarajah, Niroshan, Burgkart, Rainer, Schmidt, Burkhard, Hempel, Dirk, Jacob, Anne, Slotta-Huspenina, Julia, Höckendorf, Ulrike, Peschel, Christian, Kern, Wolfgang, Haferlach, Torsten, Götze, Katharina S, Jilg, Stefanie, Jost, Philipp J

“…Somatic mutations in genes such as , , or adversely affect the outcome of patients with myelodysplastic syndromes (MDS). Since selective BCL-2 inhibition is a…”
Get full text

Inhibition of PLK1 by capped‐dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis by Dill, Veronika, Kauschinger, Johanna, Hauch, Richard T., Buschhorn, Lars, Odinius, Timo O., Müller‐Thomas, Catharina, Mishra, Ritu, Kyncl, Michele C., Schmidt, Burkhard, Prodinger, Peter M., Hempel, Dirk, Bellos, Frauke, Höllein, Alexander, Kern, Wolfgang, Haferlach, Torsten, Slotta‐Huspenina, Julia, Bassermann, Florian, Peschel, Christian, Götze, Katharina S., Waizenegger, Irene C., Höckendorf, Ulrike, Jost, Philipp J., Jilg, Stefanie

“…Introduction Targeting the cell cycle machinery represents a rational therapeutic approach in myelodysplastic syndromes (MDS) and secondary acute myeloid…”
Get full text

Elevated RIPK3 correlates with disease burden in myelofibrosis by Dill, Veronika, Wagner, Celina V., Keller, Eva C., Fernandez-Hernandez, Francisco Jose, Shoumariyeh, Khalid, Odinius, Timo O., Buschhorn, Lars, Hauch, Richard T., Suren, Christian, Hecker, Judith S., Herhaus, Peter, Sandherr, Michael, Schmidt, Burkhard, Slotta-Huspenina, Julia, Bassermann, Florian, Höckendorf, Ulrike, Jilg, Stefanie, Branca, Caterina, Vosberg, Sebastian, Jost, Philipp J.

Get full text

Combination of 5-Azacytidine and ABT-199 Has a Synergistic Apoptotic Effect in High-Risk MDS/sAML after HMA Failure by Jilg, Stefanie, Kauschinger, Johanna, Reidel, Veronika, Müller-Thomas, Catharina, Hauch, Richard, Schauwecker, Johannes, Schmidt, Burkhard, Höckendorf, Ulrike, Peschel, Christian, Götze, Katharina, Jost, Philipp J.

“…Introduction: Myelodysplastic syndromes (MDS) are one of the most common haematological disorders of the older patient. Allogeneic stem cell stransplantation…”
Get full text

Impact of COVID-19 Related Restrictions on Infections in Children with Cancer or after Hematopoietic SCT by Hauch, Richard, Hinrichs, Malena, Ruhwald, Rebecca, Schrum, Johanna, Rutkowski, Stefan, Woessmann, Wilhelm, Winkler, Beate

“…Infections are a major concern for immunocompromised children. We investigated whether non-pharmaceutical interventions (NPIs) implemented in the general…”
Get more information